Literature DB >> 14634126

Regulation and phenotype of an innate Th1 cell: role of cytokines and the p38 kinase pathway.

Jeffrey J Yu1, Catherine S Tripp, John H Russell.   

Abstract

We have explored the phenotype and regulation of Th1 cell activation by the cytokines IL-12 and IL-18. We demonstrate that these two cytokines selectively induce IFN-gamma in a differentiated Th1 cell population through the previously described p38 mitogen-activated protein (MAP) kinase pathway. Using a highly selective p38 MAP kinase inhibitor, we demonstrate that it is possible to block IFN-gamma induction from activated, differentiated Th1 cells via p38 MAP kinase without disrupting the activation and differentiation of naive T cells or the proliferation of naive or differentiated T cells. In addition, IL-12 and IL-18 provide an Ag and IL-2-independent survival signal to this uniquely differentiated Th1 cell population. We hypothesize that this Ag-independent survival of Th1 cells may participate in an innate inflammatory loop with monocytes at the sites of chronic inflammation. In addition, p38 MAP kinase inhibition of this cytokine-regulated pathway may be a unique mechanism to inhibit chronic inflammation without disruption of Ag-driven activation and function of naive T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634126     DOI: 10.4049/jimmunol.171.11.6112

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  p38α regulates cytokine-induced IFNγ secretion via the Mnk1/eIF4E pathway in Th1 cells.

Authors:  María Salvador-Bernáldez; Sara B Mateus; Iván Del Barco Barrantes; Simon C Arthur; Carlos Martínez-A; Angel R Nebreda; Jesús M Salvador
Journal:  Immunol Cell Biol       Date:  2017-06-14       Impact factor: 5.126

Review 2.  Intestine immune homeostasis after alcohol and burn injury.

Authors:  Xiaoling Li; Adam M Hammer; Juan L Rendon; Mashkoor A Choudhry
Journal:  Shock       Date:  2015-06       Impact factor: 3.454

3.  The regulation of Th1 responses by the p38 MAPK.

Authors:  Ziyan Yang; Xia Zhang; Patricia A Darrah; David M Mosser
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

4.  Bone morphogenetic protein 7 promotes resistance to immunotherapy.

Authors:  Maria Angelica Cortez; Fatemeh Masrorpour; Cristina Ivan; Jie Zhang; Ahmed I Younes; Yue Lu; Marcos R Estecio; Hampartsoum B Barsoumian; Hari Menon; Mauricio da Silva Caetano; Rishab Ramapriyan; Jonathan E Schoenhals; Xiaohong Wang; Ferdinandos Skoulidis; Mark D Wasley; George Calin; Patrick Hwu; James W Welsh
Journal:  Nat Commun       Date:  2020-09-24       Impact factor: 14.919

5.  ERK and not p38 pathway is required for IL-12 restoration of T cell IL-2 and IFN-gamma in a rodent model of alcohol intoxication and burn injury.

Authors:  Xiaoling Li; Irshad H Chaudry; Mashkoor A Choudhry
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

6.  Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.

Authors:  Ludmila Jirmanova; Dandapantula N Sarma; Dragana Jankovic; Paul R Mittelstadt; Jonathan D Ashwell
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

7.  TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.

Authors:  Yashaswini Kannan; Mark S Wilson
Journal:  J Clin Cell Immunol       Date:  2012

8.  Resolution of LPS-induced airway inflammation and goblet cell hyperplasia is independent of IL-18.

Authors:  J Foster Harris; Jay Aden; C Rick Lyons; Yohannes Tesfaigzi
Journal:  Respir Res       Date:  2007-03-12

9.  Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.

Authors:  Jason R Lees; Paul T Golumbek; Julia Sim; Denise Dorsey; John H Russell
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

Review 10.  The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells.

Authors:  Francis Dodeller; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2006-02-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.